Covered Stents for Treatment of Visceral Artery Aneurysms: A Multicenter Study
Chenyang Qiu,Zhao Liu,Lirui Huang,Lianrui Guo,Wei Lu,Hongkun Zhang,Yangyan He,Lu Tian,Donglin Li,Xiaohui Wang,Yi Jin,Ziheng Wu
DOI: https://doi.org/10.1016/j.jvir.2022.03.009
IF: 3.682
2022-03-01
Journal of Vascular and Interventional Radiology
Abstract:PurposeTo evaluate the safety and efficacy of covered stents for visceral artery aneurysms (VAA).MethodsThis multicenter retrospective study included patients with VAAs that were treated with covered stents between January 2015 and December 2020. A total of 65 patients (mean age, 58 years [range, 27-89]) with 70 VAAs (60 true aneurysms [86%], 10 pseudoaneurysms [14%]) were included. A total of 48 patients (74%) were asymptomatic. Patient demographics, endovascular treatments, and follow-up results were analyzed.ResultsAll patients received covered stents. The mean diameter for symptomatic aneurysms was 2.9 cm (range 1.0-7.6) and for asymptomatic aneurysms was 2.5 cm (range 1.0-9.0). A total of 89% of the asymptomatic aneurysms had a saccular shape. The mean distance between the ostium of the artery in which the aneurysm occurred and the aneurysm was 3.9 cm (median, 3.0 cm [range 0.5-10]). Additional coil embolization was used in seven aneurysms (10%). During the procedure, 68(97%) aneurysms were completely excluded, while two (3%) had Type Ib endoleak. After a mean follow-up of 20 months (range 1-75), all patients were asymptomatic. Four endoleaks were recorded and left to close observation. Except for four stents (7%) that had mild restenosis, the rest of the stents were patent.ConclusionPlacement of covered stents in patients with VAAs could exclude aneurysms and maintain artery patency.
radiology, nuclear medicine & medical imaging,peripheral vascular disease